We are live on ! Find out more
KOSP

K O S PHARMACEUTICALS INC
KOSP

Delisted

KOSP was delisted on the 14th of December, 2006.

Back to rankings

2 hedge funds and large institutions have $3.43M invested in K O S PHARMACEUTICALS INC in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

13% less capital invested

Capital invested by funds: $3.95M → $3.43M (-$525K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SHFA
SS&H Financial Advisors
Michigan
-$1.1M

KOSP Hedge Fund Activity: Q4 2022 in Review

2 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in K O S PHARMACEUTICALS INC (KOSP) for Q4 2022, worth a combined $3.43M — down 13% from $3.95M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new KOSP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest seller was SS&H Financial Advisors, cutting an estimated $1.1M.

  • 2 institutional investors held K O S PHARMACEUTICALS INC (KOSP) as of Q4 2022, up from 1 in Q3 2022.
  • Funds reported $3.43M of K O S PHARMACEUTICALS INC stock for Q4 2022, down 13% quarter-over-quarter.
  • 1 fund opened new K O S PHARMACEUTICALS INC positions in Q4 2022 and 0 closed out, a net change of +1 holder.
  • The largest K O S PHARMACEUTICALS INC seller in Q4 2022 was SS&H Financial Advisors, an estimated $1.1M sold.

Based on aggregated 13F filings for Q4 2022.